Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.43 |
| ▸ | NPY1R | P25929 | 2/20 | 0.43 |
| ▸ | NPY4R | P50391 | 2/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.43 |
| ▸ | GRPR | P30550 | 1/20 | 0.42 |
| ▸ | RAMP3 | O60896 | 3/20 | 0.42 |
| ▸ | CALCR | P30988 | 3/20 | 0.42 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30578726 | 0.94 | TFPI (0.49) | TFPINPY5RNPY1RNPY4RRXFP1 | |
| SCHEMBL30471854 | 0.92 | NPY4R (0.45) | TFPINPY5RNPY1RNPY4R | |
| SCHEMBL29523429 | 0.90 | RXFP1 (0.52) | TFPIRXFP1 | |
| SCHEMBL30880897 | 0.87 | TFPI (0.49) | TFPINPY5RNPY1RNPY4RRXFP1 | |
| SCHEMBL30182730 | 0.87 | NPY4R (0.46) | TFPINPY5RNPY1RNPY4R | |
| SCHEMBL31461988 | 0.86 | NPY4R (0.47) | TFPINPY5RNPY1RNPY4R | |
| SCHEMBL30140951 | 0.86 | NPY4R (0.47) | TFPINPY5RNPY1RNPY4R | |
| SCHEMBL32670412 | 0.86 | TFPI (0.45) | TFPINPY5RNPY1RNPY4RCXCR4 | |
| SCHEMBL31462045 | 0.85 | TFPI (0.51) | TFPINPY5RNPY1RNPY4RRXFP1 | |
| SCHEMBL30084577 | 0.85 | TFPI (0.48) | TFPINPY5RNPY1RNPY4RRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116769027-B | anti-IL-17 nanobody, polypeptide and application thereof | 康元医疗科技(大连)有限公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-116769027-A | anti-IL-17 nanobody, polypeptide and application thereof | 康元医疗科技(大连)有限公司 | 2023-09-19 | — | — | CN | disclosed |